Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney Injury: The Case of C-C Motif Chemokine Ligand 14 (CCL14)

Echeverri J, Martins R, Harenski K, Kampf JP, McPherson P, Textoris J, Koyner JL

ClinicoEconomics and Outcomes Research 2024, 16:1-12

Published Date: 12 January 2024